Tianjin Medical University Cancer Institute & Hospital ( Site 0804 )
Welcome,         Profile    Billing    Logout  
 11 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yao, Xin
SOLARIS, NCT04094688: Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer

Active, not recruiting
3
455
US
Bevacizumab, Oxaliplatin, Leucovorin Calcium, Fluorouracil, Irinotecan Hydrochloride, Irinotecan, Cholecalciferol, Vitamin D3, Quality-of-Life Assessment, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Colorectal Adenocarcinoma
01/26
07/26
CYCLONE 3, NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)

Active, not recruiting
3
900
Europe, Canada, Japan, US, RoW
Abemaciclib, LY2835219, Abiraterone, Prednisone or Prednisolone, Placebo for Abemaciclib
Eli Lilly and Company
Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs, Antineoplastic Agents, Antineoplastic Agents, Hormonal, Androgens, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Abiraterone Acetate, Steroid Synthesis Inhibitors, Cytochrome P-450, Enzyme Inhibitors, Prednisone, Prednisolone, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
02/24
10/27
NCT04691804 / 2020-006063-28: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

Active, not recruiting
3
496
Europe, US, RoW
Fuzuloparib , Abiraterone acetate and Prednisone, SHR3162, Fuzuloparib Placebo， Abiraterone acetate and Prednisone
Jiangsu HengRui Medicine Co., Ltd.
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
12/26
12/26
CYCLONE 2, NCT03706365 / 2016-004276-21: A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer

Active, not recruiting
2/3
350
Europe, Japan, US, RoW
Abemaciclib, LY2835219, Abiraterone Acetate, Prednisone, Placebo
Eli Lilly and Company
Prostate Cancer
01/24
06/26
NCT04137107: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer

Active, not recruiting
2/3
220
US, RoW
Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Stage II Colorectal Cancer AJCC V8, Stage III Colorectal Cancer AJCC V8
02/26
12/26
MRG002-006, NCT04839510: A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer

Recruiting
2
58
RoW
MRG002
Shanghai Miracogen Inc.
Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma
06/22
09/22
NCT04492293: An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Recruiting
2
115
RoW
ICP-192
Beijing InnoCare Pharma Tech Co., Ltd.
Bladder Urothelial Cancer
12/24
06/25
NCT06220838: Study SC-101 in Subjects with Advanced Malignancies

Recruiting
1
100
RoW
SC-101
Tianjin ConjuStar Biologics Co., Ltd.
Advanced Solid Tumor
06/25
12/25
NCT06730659: A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors

Recruiting
1
36
RoW
CHT101
Tianjin Medical University Cancer Institute and Hospital, Nanjing Calmhome Cell and Gene Engineering Institute Co., Ltd.
Relapsed / Refractory Solid Tumor
04/27
04/39
NCT05607693: A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects

Recruiting
1
52
RoW
SHR3680 tablets
Jiangsu HengRui Medicine Co., Ltd.
Castration-Resistant Prostate Cancer
11/24
11/24
NCT06717009: A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.

Not yet recruiting
N/A
350
RoW
Preoperative three-dimensional reconstruction
Tianjin Medical University Cancer Institute and Hospital, Sir Run Run Shaw Hospital, Zhejiang University, The First Affiliated Hospital of Zhengzhou University, Peking University First Hospital, Liaoning Cancer Hospital & Institute, The Second Affiliated Hospital of Dalian Medical University, First Affiliated Hospital of Chongqing Medical University, Qilu Hospital of Shandong University, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hebei Medical University Fourth Hospital, West China Hospital, Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, China, Sun Yat-sen University Tumor Hospital, Shanghai Cancer Hospital, China, Shengjing hospital affiliated to China Medical University
Kidney Neoplasms / Surgery, Robotic Surgical Procedures, Imaging, Three-Dimensional / Methods, Nephrectomy / Methods
09/26
10/27

Download Options